top of page

FOXC1 Molecular Mechanisms

FOXC1 PATHWAYS

The FOXC1 gene is activated in the nucleus of tumor cells, where the genetic code is transcribed into messenger RNA (mRNA) and exported into the cytoplasm for translation by ribosomes into  FOXC1 transcription factor protein.  Under the direction of nuclear localization signals (i.e., NR2F2), TF FOXC1 trans locates back into the nucleus and activates its targeted gene network.  The presence of TF FOXC1 in tumor cell nuclei as visualized via Veresca FOXC1  IHC  test provides valuable information on the proportion and extent to which FOXC1+ cells with high metastatic propensity are present in the tumor landscape. 

FOXC1 Molecular Mechanism.png

The Battle Between FOXC1 and ER

Selected White Papers from the VERESCA Library

Screenshot (142)_edited.jpg
Screenshot (142)_edited.jpg
Screenshot (144).png
Screenshot (142)_edited.jpg

FOXC1 Prometastatic Cancer

Slide1.PNG
Slide2.PNG
Slide3.PNG

VERESCA    PRECISION ONCOLOGY

 US | Onconostic Technologies, Inc. 

 EU | 3N Diagnostics Ltd.

​

Send all correspondence to:

​

Email: info@FOXC1.email

Tel: +1 (858) 223-3005

​

PO Box  910163

San Diego, California 92191  USA

®

 © 2023 All rights reserved. 3N Diagnostics Ltd. (NI618099) Murray House, 1 Murray Street, Bellfast, Antrim BT1 6DN, Northern Ireland, United Kingdom

VERESCA and the             logo are trademarks owned by 3N Diagnostics and registered in certain counties.    

​

Products are protected by patents and pending patents in certain countries.   www.FOXC1.info/patents​

​

* Products approved for In Vitro Diagnostic Use have cleared regulatory review in the European Union and certain countries throughout the globe. Contents herein should not be construed to constitute marketing,  clinical advice or guidance in other jurisdictions.

fox logo pink tm.png
TERMS & CONDITIONS
PRIVACY POLICY
bottom of page